1. Home
  2. QMCO vs RANI Comparison

QMCO vs RANI Comparison

Compare QMCO & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Corporation

QMCO

Quantum Corporation

N/A

Current Price

$24.09

Market Cap

129.1M

Sector

Technology

ML Signal

N/A

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

N/A

Current Price

$0.86

Market Cap

106.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QMCO
RANI
Founded
1980
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.1M
106.9M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
QMCO
RANI
Price
$24.09
$0.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$10.50
$7.50
AVG Volume (30 Days)
2.3M
685.3K
Earning Date
02-17-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
64.34
57.14
EPS
N/A
N/A
Revenue
$372,827,000.00
$1,633,000.00
Revenue This Year
$0.32
$274.77
Revenue Next Year
$8.35
$79.44
P/E Ratio
N/A
N/A
Revenue Growth
6.65
58.85
52 Week Low
$4.19
$0.44
52 Week High
$27.80
$3.87

Technical Indicators

Market Signals
Indicator
QMCO
RANI
Relative Strength Index (RSI) 66.27 54.83
Support Level $5.67 $0.86
Resistance Level $27.80 $0.94
Average True Range (ATR) 2.22 0.05
MACD -0.02 0.00
Stochastic Oscillator 54.21 62.39

Price Performance

Historical Comparison
QMCO
RANI

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: